Alejandro Mata
Alejandro Mata has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- C. Oliver Kappe
Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, 8010 Graz, Austria
1 shared publication - David Cantillo
Institute of Chemistry, NAWI Graz, University of Graz, Heinrichstraße 28, 8010 Graz, AUSTRIA
1 shared publication - Leandro Soter de Mariz e Miranda
CY Cergy Paris Université, CNRS, BioCIS, 95000, Cergy-Pontoise, France
1 shared publication - Raquel A. C. Leão
Universidade Federal do Rio de Janeiro, Biocatalysis and Organic Syntheis Group, Av. Athos da Silveira Ramos 149, Centro de Tecnologia, Bloco A, 21941909, Ilha do Fundão, Rio de Janeiro, Brazil
1 shared publication - Renata M. Aguiar
Biocatalysis and Organic Synthesis Group, ChemistryInstitute, Federal Universityof Rio de Janeiro, 21941-909, Rio de Janeiro, Brazil.
1 shared publication - Rodrigo Octavio Mendonca Alves De Souza
Federal University of Rio de Janeiro
1 shared publication
Latest Publications
- 22 January 2019
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 17 (6) , 1552-1557
Continuous-flow protocol for the synthesis of enantiomerically pure intermediates of anti epilepsy and anti tuberculosis active pharmaceutical ingredients
Continuous-flow production of chiral intermediates plays an important role in the development of building blocks for Active Pharmaceutical Ingredients (APIs), being α-amino acids and their derivatives widely applied as building blocks. In this work we developed two different strategies for the synthesis of intermediates used on the synthesis of levetiracetam/brivaracetam and ethambutol. The results obtained show that methionine methyl ester can be continuously converted to the desired ethambutol intermediate by RANEY® Nickel dessulfurization/reduction strategy whereas levetiracetam/brivaracetam intermediates could be synthesized by both RANEY® Nickel (without H2) and Pd/C–H2 approach or by photochemical desulfurization.
- 22 January 2019
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 17 (6) , 1552-1557
Continuous-flow protocol for the synthesis of enantiomerically pure intermediates of anti epilepsy and anti tuberculosis active pharmaceutical ingredients
Continuous-flow production of chiral intermediates plays an important role in the development of building blocks for Active Pharmaceutical Ingredients (APIs), being α-amino acids and their derivatives widely applied as building blocks. In this work we developed two different strategies for the synthesis of intermediates used on the synthesis of levetiracetam/brivaracetam and ethambutol. The results obtained show that methionine methyl ester can be continuously converted to the desired ethambutol intermediate by RANEY® Nickel dessulfurization/reduction strategy whereas levetiracetam/brivaracetam intermediates could be synthesized by both RANEY® Nickel (without H2) and Pd/C–H2 approach or by photochemical desulfurization.